ACHN

Achillion Pharmaceuticals, Inc.
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

115 hedge funds and large institutions have $627M invested in Achillion Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+21
Holders Change %
+22.34%
% of All Funds
3.31%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
41
Increased
32
Reduced
29
Closed
20
Calls
$73.8M
Puts
$17.6M
Net Calls
+$56.3M
Net Calls Change
+$31.7M
Name Holding Trade Value Shares
Change
Shares
Change %
SG Americas Securities
126
SG Americas Securities
New York
-$90K -27,400 Closed
T. Rowe Price Associates
127
T. Rowe Price Associates
Maryland
-$90K -27,400 Closed
William Blair & Company
128
William Blair & Company
Illinois
-$55K -16,800 Closed
V
129
Veritable
Delaware
-$53K -16,000 Closed
BJ
130
BlackRock Japan
Japan
-$47K -14,262 Closed
Nisa Investment Advisors
131
Nisa Investment Advisors
Missouri
-$37K -11,200 Closed
CA
132
Commerzbank Aktiengesellschaft
Germany
-$34K -10,355 Closed
GC
133
Guggenheim Capital
Illinois
-$33K -10,015 Closed
Zurich Cantonal Bank
134
Zurich Cantonal Bank
Switzerland
-$27K -8,100 Closed
SFSIG
135
San Francisco Sentry Investment Group
California
-$14K -4,200 Closed